Oncode Institute is based on three pillars: excellent science, collaboration, and valorisation. We offer a unique ecosystem where science and valorisation unite, shortening the path from laboratory to patient. We invest in a carefully selected group of outstanding researchers – our Oncode Investigators – and give them the funding and freedom to think outside the box.

Only by joining forces can we outsmart cancer. That is why we encourage cooperation across borders between institutes and between disciplines. Through proactive valorisation, we translate research results into concrete social and economic value for society. We act as a connector, facilitator, and booster. In doing so, we strengthen cancer research, the Dutch economy, and patient care. Oncode Institute catalyses scientific breakthroughs and new therapies, contributing to the future of cancer research and better treatment options for patients worldwide.

Oncode Institute unites researchers from 13 different partner institutes in a common mission: to accelerate breakthrough discoveries and drive their translation into new diagnostics and treatments for cancer patients. To increase the impact of our research, we also collaborate with doctors, companies, and patients.

Oncode Institute’s research team is a select group of 62 Oncode Investigators and their teams. They form a research community of more than 750 scientists. The community conducts basic and applied research to achieve breakthroughs in cancer diagnostics and treatment. Oncode Institute creates optimal conditions in which top researchers have the space to pioneer and conduct in-depth research into how cancer works.

Oncode Institute collaborates with a wide range of partners. Research organisations and teaching hospitals provide expertise and facilities for research, and patient organisations contribute to understanding patients’ medical needs. The biotechnology and pharmaceutical industries play a critical role in developing and implementing new diagnostics and therapies. These collaborations allow us to combine knowledge, resources, and technologies. Together, we promote the translation of basic research into tangible clinical applications and accelerate progress in the treatment of cancer patients.

Oncode Institute is only able to realise its mission thanks to the support of its funders – KWF Kankerbestrijding, the Dutch Ministry of Economic Affairs, the Dutch Ministry of Education, Culture and Science, the Dutch Ministry of Health, Welfare and Sport (through ZonMw), and the top sector Life Sciences & Health (Health~Holland). All these organizations support Oncode Institute with funding and policy-making. Their contributions enable us to invest in pioneering research, cutting-edge technologies, and valorisation programmes that bring scientific discoveries to practice and patients faster.